Abstract
Objective and design
α-Melanoycte stimulating hormone (α-MSH), a neuropeptide hormone with reported anti-microbial and immuno-modulatory properties in vitro, has previously been detected in the cerebrospinal fluid of children with bacterial meningitis. We investigated the therapeutic effects of α-MSH administration on Neisseria meningitidis infection of human meningeal cell cultures in vitro.
Materials and methods
Meningeal cell lines (n = 2) were infected with meningococci (102–108 cfu/monolayer), isolated bacterial outer membranes (OM; 1 μg/ml) or lipo-oligosaccharide (LOS; 1 μg/ml) with and without α-MSH (10−5–10 μM). Bacterial adherence was quantified at 6 h, and cytokine production and microbicidal activity of α-MSH for meningococci were assessed at 24 h.
Results
Compared with infection by meningococci alone, α-MSH (10 μM) up-regulated secretion of IL-6 and IL-8 (mean values increased from ~33 to 60 ng/ml), RANTES (mean values increased from ~26 to 105 ng/ml) and GM-CSF (mean values increased from ~0.3 to 1 ng/ml; P < 0.05). Upregulated secretion correlated with a neuropeptide-mediated rapid and >5-fold increase (P < 0.05) in bacterial adherence to cells and was dependent on OM components including LOS acting synergistically with α-MSH. Meningococci were resistant to the anti-microbial activity of α-MSH at all concentrations tested.
Conclusions
Our study demonstrates that a potentially therapeutic neuropeptide exerts pro-inflammatory effects during meningococcal infection in vitro and its use in the treatment of meningitis is contra-indicated.
Similar content being viewed by others
References
van Deuren M, Brandtzaeg P, van der Meer J. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev. 2000;13:144–66.
Weller RO. Nervous system. In: Berry MM, Standring SM, Bannister LH, editors. Grays anatomy. London: Churchill Livingstone; 1995. p. 901–1398.
Brandtzaeg P. Pathogenesis of meningococcal infections. In: Cartwright KAV, editor. Meningococcal disease. UK: Wiley; 1995. p. 71–114.
Leib SL, Tauber MG. Pathogenesis of bacterial meningitis. Infect Dis Clin North Am. 1999;13:527–48.
Weber JR, Tuomanen E. Cellular damage in bacterial meningitis: an interplay of bacterial and host driven toxicity. J Neuroimmunol. 2007;184:45–52.
Christodoulides M, Heckels JE, Weller RO. The role of the leptomeninges in meningococcal meningitis. In: Ferreiros C, Criado MT, Vazquez J, editors. Emerging strategies in the fight against meningitis. UK: Horizon Press; 2002. p. 1–37.
Stolzenberg ED, Anderson GM, Ackermann MR, Whitlock RH, Zasloff M. Epithelial antibiotic induced in states of disease. Proc Natl Acad Sci USA. 1997;94:8686–90.
Bergman P, Johansson L, Wan H, Jones A, Gallo RL, Gudmundsson GH, et al. Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection. Infect Immun. 2006;74:6982–91.
Ichiyama T, Nishikawa M, Hayashi T, Hayashi S, Ryozawa M, Furukawa S. Cerebrospinal fluid concentrations of alpha-melanocyte-stimulating hormone in bacterial and aseptic meningitis. Acta Paediatr. 2000;89:803–5.
Hadley ME, Haskell-Luevano C. The proopiomelanocortin system. Ann NY Acad Sci. 1999;885:1–21.
Catania A, Colombo G, Rossi C, Carlin A, Sordi A, Lonati C, et al. Antimicrobial properties of alpha-MSH and related synthetic melanocortins. ScientificWorldJournal. 2006;6:1241–6.
Donnarumma G, Paoletti I, Buommino E, Tufano MA, Baroni A. Alpha-MSH reduces the internalization of Staphylococcus aureus and down-regulates HSP 70, integrins and cytokine expression in human keratinocyte cell lines. Exp Dermatol. 2004;13:748–54.
Lipton JM, Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol Today. 1997;18:140–5.
Oktar BK, Alican I. Modulation of the peripheral and central inflammatory responses by alpha-melanocyte stimulating hormone. Curr Protein Pept Sci. 2002;3:623–8.
Wong KY, Rajora N, Boccoli G, Catania A, Lipton JM. A potential mechanism of local anti-inflammatory action of alpha-melanocyte-stimulating hormone within the brain: modulation of tumor necrosis factor-alpha production by human astrocytic cells. Neuroimmunomodulation. 1997;4:37–41.
Catania A, Cutuli M, Garofalo L, Airaghi L, Valenza F, Lipton JM, et al. Plasma concentrations and anti-l-cytokine effects of alpha-melanocyte stimulating hormone in septic patients. Crit Care Med. 2000;28:1403–7.
Catania A, Garofalo L, Cutuli M, Gringeri A, Santagostino E, Lipton JM. Melanocortin peptides inhibit production of proinflammatory cytokines in blood of HIV-infected patients. Peptides. 1998;19:1099–104.
Taherzadeh S, Sharma S, Chhajlani V, Gantz I, Rajora N, Demitri MT, et al. Alpha-MSH and its receptors in regulation of tumor necrosis factor-alpha production by human monocyte macrophages. Am J Physiol. 1999;276:R1289–94.
Bhardwaj RS, Schwarz A, Becher E, Mahnke K, Aragane Y, Schwarz T, et al. Pro-opiomelanocortin-derived peptides induce IL-10 production in human monocytes. J Immunol. 1996;156:2517–21.
Ichiyama T, Zhao H, Catania A, Furukawa S, Lipton JM. Alpha-melanocyte-stimulating hormone inhibits NF-kappa B activation and I kappa B alpha degradation in human glioma cells and in experimental brain inflammation. Exp Neurol. 1999;157:359–65.
Manna SK, Aggarwal BB. Alpha-melanocyte-stimulating hormone inhibits the nuclear transcription factor NF-kappa B activation induced by various inflammatory agents. J Immunol. 1998;161:2873–80.
Haycock JW, Rowe SJ, Cartledge S, Wyatt A, Ghanem G, Morandini R, et al. Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. J Biol Chem. 2000;275:15629–36.
Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM. The neuropeptide alpha-MSH has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides. 1996;17:675–9.
Star RA, Rajora N, Huang JJ, Stock RC, Catania A, Lipton JM. Evidence of autocrine modulation of macrophage nitric oxide synthase by alpha-melanocyte-stimulating hormone. Proc Natl Acad Sci USA. 1995;92:8016–20.
Mountjoy KG, Wong J. Obesity, diabetes and functions for proopiomelanocortin-derived peptides. Mol Cell Endocrinol. 1997;128:171–7.
Gantz I, Fong TM. The melanocortin system. Am J Physiol Endocrinol Metab. 2003;284:E468–74.
Rees JL. Genetics of hair and skin color. Annu Rev Genet. 2003;37:67–90.
Seeley RJ, Drazen DL, Clegg DJ. The critical role of the melanocortin system in the control of energy balance. Annu Rev Nutr. 2004;24:133–49.
Hardy SJ, Christodoulides M, Weller RO, Heckels JE. Interactions of Neisseria meningitidis with cells of the human meninges. Mol Microbiol. 2000;36:817–29.
McGuinness BT, Clarke IN, Lambden PR, Barlow AK, Poolman JT, Jones DM, et al. Point mutation in meningococcal porA gene associated with increased endemic disease. Lancet. 1991;337:514–7.
Christodoulides M, Makepeace BL, Partridge K, Kaur D, Fowler MI, Weller RO, et al. Interaction of Neisseria meningitidis with human meningeal cells induces the secretion of a distinct group of chemotactic, pro-inflammatory and growth-factor cytokines. Infect Immun. 2002;70:4035–44.
Cheng Z, Xiong ZM, Subbarayan M, Chen XY, Gambhir SS. Cu-64-labeled alpha-melanocyte-stimulating hormone analog for MicroPET imaging of melanocortin 1 receptor expression. Bioconjug Chem. 2007;18:765–72.
Stephens DS, Edwards KM, Morris FMG. Pili and outer membrane appendages on Neisseria meningitidis in the cerebrospinal fluid of an infant. J Infect Dis. 1982;146:568.
Brogden KA, Guthmiller JM, Salzet M, Zasloff M. The nervous system and innate immunity: the neuropeptide connection. Nat Immunol. 2005;6:558–64.
Kowalska K, Carr DB, Lipkowski AW. Direct antimicrobial properties of substance P. Life Sci. 2002;71:747–50.
Goumon Y, Lugardon K, Kieffer B, Lefevre JF, Van Dorsselaer A, Aunis D, et al. Characterization of antibacterial COOH-terminal proenkephalin-A-derived peptides (PEAP) in infectious fluids: importance of enkelytin, the antibacterial PEAP(209–237) secreted by stimulated chromaffin cells. J Biol Chem. 1998;273:29847–56.
Shimizu M, Shigeri Y, Tatsu Y, Yoshikawa S, Yumoto N. Enhancement of antimicrobial activity of neuropeptide Y by N-terminal truncation. Antimicrob Agents Chemother. 1998;42:2745–6.
Vouldoukis I, Shai Y, Nicolas P, Mor A. Broad spectrum antibiotic activity of skin-PYY. FEBS Lett. 1996;380:237–40.
Gonzalez-Rey E, Chorny A, Varela N, Robledo G, Delgado M. Urocortin and adrenomedullin prevent lethal endotoxemia by down-regulating the inflammatory response. Am J Pathol. 2006;168:1921–30.
Gonzalez-Rey E, Chorny A, Robledo G, Delgado M. Cortistatin, a new antiinflammatory peptide with therapeutic effect on lethal endotoxemia. J Exp Med. 2006;203:563–71.
Bateman A, MacLeod RJ, Lembessis P, Hu J, Esch F, Solomon S. The isolation and characterization of a novel corticostatin/defensin-like peptide from the kidney. J Biol Chem. 1996;271:10654–9.
Kastenbauer S, Koedel U, Brzoska T, Luger TA, Pfister HW. Failure of alpha-melanocyte stimulating hormone to attenuate cerebral complications in experimental pneumococcal meningitis. J Neuroimmunol. 2001;116:56–61.
Cutuli M, Cristiani S, Lipton JM, Catania A. Antimicrobial effects of alpha-MSH peptides. J Leukoc Biol. 2000;67:233–9.
Gorter AD, Oostrik J, van der Ley P, Hiemstra PS, Dankert J, van Alphen L. Involvement of lipooligosaccharides of Haemophilus influenzae and Neisseria meningitidis in defensin-enhanced bacterial adherence to epithelial cells. Microb Pathog. 2003;34:121–30.
Tatro JB. Receptor biology of the melanocortins, a family of neuroimmunomodulatory peptides. Neuroimmunomodulation. 1996;3:259–84.
Robinson SJ, Healy E. Human melanocortin 1 receptor (MC1R) gene variants alter melanoma cell growth and adhesion to extracellular matrix. Oncogene. 2002;21:8037–46.
Kiss M, Kemeny L, Gyulai R, Michel G, Husz S, Kovacs R, et al. Effects of the neuropeptides substance P, calcitonin gene-related peptide and alpha-melanocyte-stimulating hormone on the IL-8/IL-8 receptor system in a cultured human keratinocyte cell line and dermal fibroblasts. Inflammation. 1999;23:557–67.
Lindberg C, Hjorth E, Post C, Winblad B, Schultzberg M. Cytokine production by a human microglial cell line: effects of beta-amyloid and alpha-melanocyte-stimulating hormone. Neurotox Res. 2005;8:267–76.
Acknowledgments
P.K. was a PhD student supported by the British Skin Foundation. The work was supported by funding from the British Skin Foundation and the Meningitis Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Additional information
Responsible Editor: G. Wallace.
Rights and permissions
About this article
Cite this article
Kumar, P., Williams, J.N., Durkin, K.L. et al. Neuropeptide α-MSH exerts pro-inflammatory effects on Neisseria meningitidis infection in vitro. Inflamm. Res. 59, 105–113 (2010). https://doi.org/10.1007/s00011-009-0076-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-009-0076-9